3019
Hybridomas in cacer diagnosis and treatment
New York
Raven Press
c1982
xviii, 264p.: ill
Progress in cancer research and therapy, v.12
Biological Respone Modifier program U.S.
Proceeding of a workship held Feb. 1981 at Bethesa Md., Sponsord by the Biological Respone Modifier program, Division of Cancer Treatment, National Cancer Institute
Includes bibliographies and index
editors Makolm S. Mitchell, Herbert F. Oettgen
Immunological aspects -Congresses ، Cancer
Diagnostic use -Congresses ، Antibodies, Monoclonal
Therapeutic use -Congresses ، Antibodies, Monoclonal
RC
268
.
3
.
H93
1982
TI
AU Mitchel, Malcolms
AU Oettgen, H.F.
CO Biological Response Modifier Program )U.S.(
SE
Medicine
